What is LOPJLB’s current signal on INSM?

LOPJLB’s latest quantitative signal on Insmed Incorporated (INSM) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is INSM in?

Insmed Incorporated (INSM) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Insmed Incorporated (INSM) do?

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its develo…

Where is Insmed Incorporated based / listed?

Insmed Incorporated is based in US, listed on NASDAQ.

Insmed Incorporated (INSM)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$100.60+0.12%Close

SELLCRISIS · day 7

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $21.8B
Beta: 0.82
P/E (TTM): -25.60

Short % float: 6.96%
Days to cover: 6.5
SI change: +27.8%

1W: -9.47%
1M: -20.96%

vs SPY 1W: -10.63%
vs SPY 1M: -23.95%

Industry peers

FMP comparable companies · ranked by market cap

UTHRBUYUnited Therapeutics Corporation$23.3BRECOVERYQ 20$549.16+3.07%
LQDASELLLiquidia Corporation$2.4BCRISISQ 12$27.38-2.28%
AVLNSELLAvalyn Pharma Inc. Common Stock$1.1BQ -8$25.76+0.16%
TBPHBUYTheravance Biopharma Inc$883MBULLQ -1$17.03+0.00%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news